Torii Pharmaceutical Co., Ltd. (4551) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Negative results in Jun 25

DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
CASH AND EQV(HY) Lowest at JPY 74,564 MM
DEBT-EQUITY RATIO (HY) Highest at -27.19 %

With ROE of 4.58%, it has a very attractive valuation with a 1.50 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 182,880 Million (Small Cap)

P/E

33.00

Industry P/E

Dividend Yield

0.02%

Debt Equity

-0.28

Return on Equity

4.42%

Price to Book

1.49

Revenue and Profits:

Net Sales:

16,696 Million

(Quarterly Results - Jun 2025)

Net Profit:

1,197 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.16%

6 Months

48.71%

1 Year

78.87%

2 Years

69.56%

3 Years

112.59%

4 Years

119.5%

5 Years

123.91%

Torii Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.27%

EBIT Growth (5y)

15.98%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.34

Sales to Capital Employed (avg)

0.47

Tax Ratio

25.11%

Dividend Payout Ratio

66.90%

Pledged Shares

Institutional Holding

ROCE (avg)

8.52%

ROE (avg)

3.61%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.50

EV to EBIT

19.89

EV to EBITDA

18.83

EV to Capital Employed

1.76

EV to Sales

2.30

PEG Ratio

6.42

Dividend Yield

0.02%

ROCE (Latest)

8.85%

ROE (Latest)

4.58%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 12.37% vs 6.98% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -10.87% vs -2.26% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16,696.00",
          "val2": "14,858.00",
          "chgp": "12.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,548.00",
          "val2": "1,852.00",
          "chgp": "-16.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,197.00",
          "val2": "1,343.00",
          "chgp": "-10.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "86.70%",
          "val2": "118.30%",
          "chgp": "-3.16%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.59% vs 11.74% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 22.41% vs 4.44% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "60,426.00",
          "val2": "54,638.00",
          "chgp": "10.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,016.00",
          "val2": "5,271.00",
          "chgp": "33.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,042.00",
          "val2": "4,119.00",
          "chgp": "22.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "112.50%",
          "val2": "92.20%",
          "chgp": "2.03%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

16,696.00

14,858.00

12.37%

Operating Profit (PBDIT) excl Other Income

1,548.00

1,852.00

-16.41%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

1,197.00

1,343.00

-10.87%

Operating Profit Margin (Excl OI)

86.70%

118.30%

-3.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 12.37% vs 6.98% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -10.87% vs -2.26% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

60,426.00

54,638.00

10.59%

Operating Profit (PBDIT) excl Other Income

7,016.00

5,271.00

33.11%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

5,042.00

4,119.00

22.41%

Operating Profit Margin (Excl OI)

112.50%

92.20%

2.03%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 10.59% vs 11.74% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 22.41% vs 4.44% in Dec 2023

All Annual Results

Company CV

About Torii Pharmaceutical Co., Ltd.

Torii Pharmaceutical Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available